📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A novel brain-penetrant oral UGT8 inhibitor decreases in vivo galactosphingolipid biosynthesis in murine Krabbe disease. (2022)

First Author: Zaccariotto E

Attributed to: Predictive measures to stratify clinical outcomes in children and adults with Gaucher disease and responses to specific therapies funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.biopha.2022.112808

PubMed Identifier: 35290889

Publication URI: http://europepmc.org/abstract/MED/35290889

Type: Journal Article/Review

Volume: 149

Parent Publication: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

ISSN: 0753-3322